B cells in tumor metastasis: friend or foe?

被引:13
作者
Xu, Yuqiu [1 ]
Mao, Yihao [1 ]
Lv, Yang [1 ]
Tang, Wentao [1 ]
Xu, Jianmin [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
B cell; tumor metastasis; mechanism; immunotherapy; metabolism; DENDRITIC CELLS; T-CELLS; CANCER; SURVIVAL; LYMPHOCYTES; CARCINOMA; IMMUNITY; BREAST; MICROENVIRONMENT; DIFFERENTIATION;
D O I
10.7150/ijbs.79482
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis is an important cause of cancer-related death. Immunotherapy may be an effective way to prevent and treat tumor metastasis in the future. Currently, many studies have focused on T cells, whereas fewer have focused on B cells and their subsets. B cells play an important role in tumor metastasis. They not only secrete antibodies and various cytokines but also function in antigen presentation to directly or indirectly participate in tumor immunity. Furthermore, B cells are involved in both inhibiting and promoting tumor metastasis, which demonstrates the complexity of B cells in tumor immunity. Moreover, different subgroups of B cells have distinct functions. The functions of B cells are also affected by the tumor microenvironment, and the metabolic homeostasis of B cells is also closely related to their function. In this review, we summarize the role of B cells in tumor metastasis, analyze the mechanisms of B cells, and discuss the current status and prospects of B cells in immunotherapy.
引用
收藏
页码:2382 / 2393
页数:12
相关论文
共 117 条
[1]   Follicular dendritic cell networks of primary follicles and germinal centers: Phenotype and function [J].
Allen, Christopher D. C. ;
Cyster, Jason G. .
SEMINARS IN IMMUNOLOGY, 2008, 20 (01) :14-25
[2]   B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization [J].
Angeli, V ;
Ginhoux, F ;
Llodrá, J ;
Quemeneur, L ;
Frenette, PS ;
Skobe, M ;
Jessberger, R ;
Merad, M ;
Randolph, GJ .
IMMUNITY, 2006, 24 (02) :203-215
[3]  
[Anonymous], 2020, J IMMUNOTHER CANCER, V8, DOI DOI 10.1136/jitc-2020-001187
[4]  
Arabpour M, 2019, MOL IMMUNOL, V114, P172, DOI [10.1016/molimm.2019.07.019, 10.1016/j.molimm.2019.07.019]
[5]   B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].
Barbera-Guillem, E ;
Nelson, MB ;
Barr, B ;
Nyhus, JK ;
May, KF ;
Feng, L ;
Sampsel, JW .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549
[6]   Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate [J].
Bibby, Jack A. ;
Purvis, Harriet A. ;
Hayday, Thomas ;
Chandra, Anita ;
Okkenhaug, Klaus ;
Rosenzweig, Sofia ;
Aksentijevich, Ivona ;
Wood, Michael ;
Lachmann, Helen J. ;
Kemper, Claudia ;
Cope, Andrew P. ;
Perucha, Esperanza .
NATURE COMMUNICATIONS, 2020, 11 (01)
[7]   IgA transcytosis and antigen recognition govern ovarian cancer immunity [J].
Biswas, Subir ;
Mandal, Gunjan ;
Payne, Kyle K. ;
Anadon, Carmen M. ;
Gatenbee, Chandler D. ;
Chaurio, Ricardo A. ;
Costich, Tara Lee ;
Moran, Carlos ;
Harro, Carly M. ;
Rigolizzo, Kristen E. ;
Mine, Jessica A. ;
Trillo-Tinoco, Jimena ;
Sasamoto, Naoko ;
Terry, Kathryn L. ;
Marchion, Douglas ;
Buras, Andrea ;
Wenham, Robert M. ;
Yu, Xiaoqing ;
Townsend, Mary K. ;
Tworoger, Shelley S. ;
Rodriguez, Paulo C. ;
Anderson, Alexander R. ;
Conejo-Garcia, Jose R. .
NATURE, 2021, 591 (7850) :464-+
[8]   Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome [J].
Bosticardo, Marita ;
Marangoni, Francesco ;
Aiuti, Alessandro ;
Villa, Anna ;
Roncarolo, Maria Grazia .
BLOOD, 2009, 113 (25) :6288-6295
[9]  
BRODT P, 1978, J IMMUNOL, V121, P359
[10]   Targeting B cell receptor signalling in cancer: preclinical and clinical advances [J].
Burger, Jan A. ;
Wiestner, Adrian .
NATURE REVIEWS CANCER, 2018, 18 (03) :148-167